1. Home
  2. TMDX vs CERT Comparison

TMDX vs CERT Comparison

Compare TMDX & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • CERT
  • Stock Information
  • Founded
  • TMDX 1998
  • CERT 2008
  • Country
  • TMDX United States
  • CERT United States
  • Employees
  • TMDX N/A
  • CERT N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CERT Retail: Computer Software & Peripheral Equipment
  • Sector
  • TMDX Health Care
  • CERT Technology
  • Exchange
  • TMDX Nasdaq
  • CERT Nasdaq
  • Market Cap
  • TMDX 2.3B
  • CERT 2.3B
  • IPO Year
  • TMDX 2019
  • CERT 2020
  • Fundamental
  • Price
  • TMDX $127.12
  • CERT $11.36
  • Analyst Decision
  • TMDX Buy
  • CERT Buy
  • Analyst Count
  • TMDX 10
  • CERT 6
  • Target Price
  • TMDX $122.89
  • CERT $15.60
  • AVG Volume (30 Days)
  • TMDX 1.1M
  • CERT 1.7M
  • Earning Date
  • TMDX 05-08-2025
  • CERT 05-05-2025
  • Dividend Yield
  • TMDX N/A
  • CERT N/A
  • EPS Growth
  • TMDX N/A
  • CERT N/A
  • EPS
  • TMDX 1.41
  • CERT N/A
  • Revenue
  • TMDX $488,227,000.00
  • CERT $394,498,000.00
  • Revenue This Year
  • TMDX $32.58
  • CERT $11.47
  • Revenue Next Year
  • TMDX $21.65
  • CERT $9.03
  • P/E Ratio
  • TMDX $90.86
  • CERT N/A
  • Revenue Growth
  • TMDX 64.43
  • CERT 9.37
  • 52 Week Low
  • TMDX $55.00
  • CERT $8.64
  • 52 Week High
  • TMDX $177.37
  • CERT $17.76
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 76.52
  • CERT 41.96
  • Support Level
  • TMDX $118.79
  • CERT $11.17
  • Resistance Level
  • TMDX $130.48
  • CERT $11.75
  • Average True Range (ATR)
  • TMDX 4.49
  • CERT 0.42
  • MACD
  • TMDX -0.15
  • CERT -0.06
  • Stochastic Oscillator
  • TMDX 83.53
  • CERT 24.00

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Share on Social Networks: